BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35438109)

  • 21. NAD(P)H:quinone oxidoreductase 1 (NQO1) localizes to the mitotic spindle in human cells.
    Siegel D; Kepa JK; Ross D
    PLoS One; 2012; 7(9):e44861. PubMed ID: 22984577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors.
    Siegel D; Franklin WA; Ross D
    Clin Cancer Res; 1998 Sep; 4(9):2065-70. PubMed ID: 9748120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
    Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
    Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6.
    Jaiswal AK; Burnett P; Adesnik M; McBride OW
    Biochemistry; 1990 Feb; 29(7):1899-906. PubMed ID: 1691923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early diagnostic imaging of pneumonia with an ultra-sensitive two-photon near-infrared fluorescent probe.
    Song E; Lai Y; Lu H; Tang Y; Zeng L; Lin W
    J Mater Chem B; 2022 Oct; 10(40):8186-8192. PubMed ID: 36169044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer.
    Zhang K; Chen D; Ma K; Wu X; Hao H; Jiang S
    J Med Chem; 2018 Aug; 61(16):6983-7003. PubMed ID: 29712428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mitochondria-targetable two-photon fluorescent probe with a far-red to near-infrared emission for sensing hypochlorite in biosystems.
    Mao GJ; Gao GQ; Liang ZZ; Wang YY; Su L; Wang ZX; Zhang H; Ma QJ; Zhang G
    Anal Chim Acta; 2019 Nov; 1081():184-192. PubMed ID: 31446957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rational Development of Near-Infrared Fluorophores with Large Stokes Shifts, Bright One-Photon, and Two-Photon Emissions for Bioimaging and Biosensing Applications.
    Zhou L; Wang Q; Tan Y; Lang MJ; Sun H; Liu X
    Chemistry; 2017 Jun; 23(36):8736-8740. PubMed ID: 28481024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A two-photon excited near-infrared fluorescent probe for imaging peroxynitrite during drug-induced hepatotoxicity and its remediation.
    Mao GJ; Gao GQ; Dong WP; Wang QQ; Wang YY; Li Y; Su L; Zhang G
    Talanta; 2021 Jan; 221():121607. PubMed ID: 33076137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer-Specific hNQO1-Responsive Biocompatible Naphthalimides Providing a Rapid Fluorescent Turn-On with an Enhanced Enzyme Affinity.
    Park SY; Jung E; Kim JS; Chi SG; Lee MH
    Sensors (Basel); 2019 Dec; 20(1):. PubMed ID: 31861836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions of the antioxidant enzymes NAD(P)H: Quinone oxidoreductase 1 (NQO1) and NRH: Quinone oxidoreductase 2 (NQO2) with pharmacological agents, endogenous biochemicals and environmental contaminants.
    Rashid MH; Babu D; Siraki AG
    Chem Biol Interact; 2021 Aug; 345():109574. PubMed ID: 34228969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of ovarian cancer detection by a near-infrared fluorescent probe activated by human NAD(P)H: quinone oxidoreductase isozyme 1 (hNQO1).
    Nakamura Y; Shen Z; Harada T; Nagaya T; Sato K; Okuyama S; Ogata F; Choyke PL; McCarley RL; Kobayashi H
    Oncotarget; 2017 Sep; 8(37):61181-61192. PubMed ID: 28977855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NAD(P)H: quinone oxidoreductase 1 and NRH:quinone oxidoreductase 2 polymorphisms in papillary thyroid microcarcinoma: correlation with phenotype.
    Lee J; Kim KS; Lee MH; Kim YS; Lee MH; Lee SE; Kim YK; Ryu MJ; Kim SJ; Choi MJ; Jo YS
    Yonsei Med J; 2013 Sep; 54(5):1158-67. PubMed ID: 23918565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations.
    den Braver-Sewradj SP; den Braver MW; Toorneman RM; van Leeuwen S; Zhang Y; Dekker SJ; Vermeulen NPE; Commandeur JNM; Vos JC
    Chem Res Toxicol; 2018 Feb; 31(2):116-126. PubMed ID: 29281794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic evidence for NAD(P)H:quinone oxidoreductase 1-catalyzed quinone reduction on passage through the mouse pulmonary circulation.
    Lindemer BJ; Bongard RD; Hoffmann R; Baumgardt S; Gonzalez FJ; Merker MP
    Am J Physiol Lung Cell Mol Physiol; 2011 May; 300(5):L773-80. PubMed ID: 21296895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural product-inspired profluorophores for imaging NQO1 activity in tumour tissues.
    Cheng Z; Valença WO; Dias GG; Scott J; Barth ND; de Moliner F; Souza GBP; Mellanby RJ; Vendrell M; da Silva Júnior EN
    Bioorg Med Chem; 2019 Sep; 27(17):3938-3946. PubMed ID: 31327676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catalytic competence, structure and stability of the cancer-associated R139W variant of the human NAD(P)H:quinone oxidoreductase 1 (NQO1).
    Lienhart WD; Strandback E; Gudipati V; Koch K; Binter A; Uhl MK; Rantasa DM; Bourgeois B; Madl T; Zangger K; Gruber K; Macheroux P
    FEBS J; 2017 Apr; 284(8):1233-1245. PubMed ID: 28236663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A two-photon fluorescent probe with near-infrared emission for hydrogen sulfide imaging in biosystems.
    Sun W; Fan J; Hu C; Cao J; Zhang H; Xiong X; Wang J; Cui S; Sun S; Peng X
    Chem Commun (Camb); 2013 May; 49(37):3890-2. PubMed ID: 23549590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-Time Monitoring of Endogenous Cysteine Levels In Vivo by near-Infrared Turn-on Fluorescent Probe with Large Stokes Shift.
    Qi Y; Huang Y; Li B; Zeng F; Wu S
    Anal Chem; 2018 Jan; 90(1):1014-1020. PubMed ID: 29182316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells.
    Singh S; Zahid M; Saeed M; Gaikwad NW; Meza JL; Cavalieri EL; Rogan EG; Chakravarti D
    J Steroid Biochem Mol Biol; 2009 Oct; 117(1-3):56-66. PubMed ID: 19628038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.